Muscle Function, Muscle Disease, and Positron Emission Tomography-Computed Tomography: A Narrative Review

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cureus vol. 17, no. 2 (2025)
Autore principale: Yamamoto Shinji
Altri autori: Okada Yukinori
Pubblicazione:
Springer Nature B.V.
Soggetti:
Accesso online:Citation/Abstract
Full Text
Full Text - PDF
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Descrizione
Abstract:18F-fluorodeoxyglucose (18F-FDG) is a radiopharmaceutical that exhibits glucose-like kinetics and is used in positron emission tomography (PET). 18F-FDG is used for cancer diagnosis in clinical practice. However, 18F-FDG uptake is also observed in normal organs, such as the brain, liver, and heart, with high glucose consumption. Moreover, 18F-FDG uptake is also observed in muscles, where its accumulation and radioactivity reflect muscle activity. Dystonia is characterized by excessive muscle movement. Recently, 18F-FDG and technetium-99m-methoxyisobutyl isocyanide ([99mTc]MIBI) have been used for the diagnosis and botulinum toxin therapy evaluation of dystonia.This review aimed to summarize the utility of 18F-FDG-PET for the evaluation of muscle activity and diagnosis of muscle diseases such as dystonia, polymyositis, dermatomyositis, and polymyalgia rheumatica.
ISSN:2168-8184
2154-4786
DOI:10.7759/cureus.79857
Fonte:Health & Medical Collection